Related Experiment Video
Updated: May 16, 2026

12:31
A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
Published on: February 28, 2015
Amperometric immunobiosensor for α-fetoprotein using Au nanoparticles/chitosan/TiO(2)-graphene composite based
Ke-Jing Huang1, Jing Li, Ying-Ying Wu
1College of Chemistry and Chemical Engineering, Xinyang Normal University, Xinyang 464000, PR China. kejinghuang@163.com
Bioelectrochemistry (Amsterdam, Netherlands)
|November 21, 2012
Summary
A novel immunosensor uses a composite film of titanium dioxide-graphene, chitosan, and gold nanoparticles for sensitive protein detection. This label-free biosensor accurately quantifies alpha-fetoprotein (AFP) with a low limit of detection.
Area of Science:
- * Electrochemistry
- * Nanomaterials Science
- * Biosensor Technology
Background:
- * Development of sensitive and selective biosensors is crucial for early disease diagnosis.
- * Label-free detection methods reduce assay complexity and cost.
- * Nanomaterials offer unique properties for enhancing biosensor performance.
Purpose of the Study:
- * To develop a simple, label-free amperometric immunosensor for protein detection.
- * To utilize a composite film of TiO(2)-graphene, chitosan, and gold nanoparticles.
- * To immobilize antibodies for the detection of alpha-fetoprotein (AFP).
Main Methods:
- * Fabrication of a modified glassy carbon electrode (GCE) with TiO(2)-graphene, chitosan, and gold nanoparticles (AuNPs).
- * Immobilization of α-fetoprotein antibody onto the AuNPs for AFP capture.
- * Electrochemical detection using differential pulse voltammetry (DPV) to measure changes in electron transfer.
Main Results:
- * Achieved a wide detection range for AFP from 0.1 to 300 ng mL(-1).
- * Obtained a low limit of detection of 0.03 ng mL(-1) at S/N=3.
- * Demonstrated high sensitivity, selectivity, stability, and generality of the developed sensing strategy.
Conclusions:
- * The developed immunosensor provides a sensitive and reliable platform for protein detection.
- * The strategy shows potential for broader applications in detecting other biomolecules.
- * This label-free approach offers advantages for clinical diagnostics and biocompound analysis.

